BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 22130661)

  • 1. Extracellular membrane-proximal domain of HAb18G/CD147 binds to metal ion-dependent adhesion site (MIDAS) motif of integrin β1 to modulate malignant properties of hepatoma cells.
    Li Y; Wu J; Song F; Tang J; Wang SJ; Yu XL; Chen ZN; Jiang JL
    J Biol Chem; 2012 Feb; 287(7):4759-72. PubMed ID: 22130661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HAb18G/CD147 promotes radioresistance in hepatocellular carcinoma cells: a potential role for integrin β1 signaling.
    Wu J; Li Y; Dang YZ; Gao HX; Jiang JL; Chen ZN
    Mol Cancer Ther; 2015 Feb; 14(2):553-63. PubMed ID: 25534361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of HAb18G/CD147 promotes invasion and metastasis via alpha3beta1 integrin mediated FAK-paxillin and FAK-PI3K-Ca2+ pathways.
    Tang J; Wu YM; Zhao P; Yang XM; Jiang JL; Chen ZN
    Cell Mol Life Sci; 2008 Sep; 65(18):2933-42. PubMed ID: 18695939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of HAb18G/CD147 with integrin alpha6beta1 and its implications for the invasion potential of human hepatoma cells.
    Dai JY; Dou KF; Wang CH; Zhao P; Lau WB; Tao L; Wu YM; Tang J; Jiang JL; Chen ZN
    BMC Cancer; 2009 Sep; 9():337. PubMed ID: 19775453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HAb18G/CD147 inhibits starvation-induced autophagy in human hepatoma cell SMMC7721 with an involvement of Beclin 1 down-regulation.
    Gou X; Ru Q; Zhang H; Chen Y; Li L; Yang H; Xing J; Chen Z
    Cancer Sci; 2009 May; 100(5):837-43. PubMed ID: 19298604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.
    Wu J; Lu M; Li Y; Shang YK; Wang SJ; Meng Y; Wang Z; Li ZS; Chen H; Chen ZN; Bian H
    Oncogene; 2016 Oct; 35(42):5468-5479. PubMed ID: 27041581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BetaIg-h3 is involved in the HAb18G/CD147-mediated metastasis process in human hepatoma cells.
    Tang J; Zhou HW; Jiang JL; Yang XM; Li Y; Zhang HX; Chen ZN; Guo WP
    Exp Biol Med (Maywood); 2007 Mar; 232(3):344-52. PubMed ID: 17327467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HAb18G/CD147-mediated calcium mobilization and hepatoma metastasis require both C-terminal and N-terminal domains.
    Jiang JL; Chan HC; Zhou Q; Yu MK; Yao XY; Lam SY; Zhu H; Ho LS; Leung KM; Chen ZN
    Cell Mol Life Sci; 2004 Aug; 61(16):2083-91. PubMed ID: 15316657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma.
    Xu J; Xu HY; Zhang Q; Song F; Jiang JL; Yang XM; Mi L; Wen N; Tian R; Wang L; Yao H; Feng Q; Zhang Y; Xing JL; Zhu P; Chen ZN
    Mol Cancer Res; 2007 Jun; 5(6):605-14. PubMed ID: 17579119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The involvement of HAb18G/CD147 in regulation of store-operated calcium entry and metastasis of human hepatoma cells.
    Jiang JL; Zhou Q; Yu MK; Ho LS; Chen ZN; Chan HC
    J Biol Chem; 2001 Dec; 276(50):46870-7. PubMed ID: 11591720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological changes and molecular expressions of hepatocellular carcinoma cells in three-dimensional culture model.
    Wu YM; Tang J; Zhao P; Chen ZN; Jiang JL
    Exp Mol Pathol; 2009 Oct; 87(2):133-40. PubMed ID: 19615356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147.
    Zhao P; Zhang W; Tang J; Ma XK; Dai JY; Li Y; Jiang JL; Zhang SH; Chen ZN
    Cancer Sci; 2010 Feb; 101(2):387-95. PubMed ID: 20047591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HAb18G/CD147 regulates vinculin-mediated focal adhesion and cytoskeleton organization in cultured human hepatocellular carcinoma cells.
    Liang Q; Han Q; Huang W; Nan G; Xu BQ; Jiang JL; Chen ZN
    PLoS One; 2014; 9(7):e102496. PubMed ID: 25033086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of matrix stiffness relating integrin β1 signaling pathway inhibits tumor growth in vitro and in hepatocellular cancer xenografts.
    Wang C; Jiang X; Huang B; Zhou W; Cui X; Zheng C; Liu F; Bi J; Zhang Y; Luo H; Yuan L; Yang J; Yu Y
    BMC Cancer; 2021 Nov; 21(1):1276. PubMed ID: 34823500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypo-phosphorylated CD147 promotes migration and invasion of hepatocellular carcinoma cells and predicts a poor prognosis.
    Jin J; Wang SJ; Cui J; Li L; Li JY; Liu FL; Sun XX; Jiang JL; Cui HY; Chen ZN
    Cell Oncol (Dordr); 2019 Aug; 42(4):537-554. PubMed ID: 31016558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced expression of Hab18g/CD147 and activation of integrin pathway in HCC cells under 3-D co-culture conditions.
    Wu YM; Tang J; Zhao P; Chen ZN; Jiang JL
    Cell Biol Int; 2009 Feb; 33(2):199-206. PubMed ID: 19059491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YIPF2 is a novel Rab-GDF that enhances HCC malignant phenotypes by facilitating CD147 endocytic recycle.
    Qi S; Su L; Li J; Zhao P; Zhang Q; Niu X; Liu J; Jia G; Wei X; Tavernier J; Jiang J; Chen Z; Zhang S
    Cell Death Dis; 2019 Jun; 10(6):462. PubMed ID: 31189879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HAb18G/CD147 is involved in TGF-β-induced epithelial-mesenchymal transition and hepatocellular carcinoma invasion.
    Ru NY; Wu J; Chen ZN; Bian H
    Cell Biol Int; 2015 Jan; 39(1):44-51. PubMed ID: 25044444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basolateral CD147 induces hepatocyte polarity loss by E-cadherin ubiquitination and degradation in hepatocellular carcinoma progress.
    Lu M; Wu J; Hao ZW; Shang YK; Xu J; Nan G; Li X; Chen ZN; Bian H
    Hepatology; 2018 Jul; 68(1):317-332. PubMed ID: 29356040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine enhances cell invasion via activating HAb18G/CD147-EGFR-pSTAT3 signaling.
    Xu BQ; Fu ZG; Meng Y; Wu XQ; Wu B; Xu L; Jiang JL; Li L; Chen ZN
    Oncotarget; 2016 Sep; 7(38):62177-62193. PubMed ID: 27556697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.